BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 19836484)

  • 21. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Hubbard JG; Sebag F; Maweja S; Henry JF
    Arch Surg; 2006 Mar; 141(3):235-9. PubMed ID: 16549687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia.
    White ML; Doherty GM
    Surg Oncol Clin N Am; 2008 Apr; 17(2):439-59, x. PubMed ID: 18375361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.
    Machens A; Lorenz K; Dralle H
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenic patterns of genetic predisposition to endocrine tumors].
    Calender A
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review.
    Landry CS; Waguespack SG; Perrier ND
    Surg Clin North Am; 2009 Oct; 89(5):1069-89. PubMed ID: 19836485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medullary thyroid carcinoma: state of the art.
    Favia G; Iacobone M
    G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
    Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
    World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple endocrine neoplasia syndrome type 2].
    Khom'iak VV; Pavlovs'kyĭ MP; Boĭko NI; Dovgan' IuP; Gavrysh IaI; Kemin' RV
    Klin Khir; 2012 Aug; (8):55-7. PubMed ID: 23113424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine surgery.
    van Heerden JA
    J Am Coll Surg; 1998 Feb; 186(2):141-8. PubMed ID: 9482616
    [No Abstract]   [Full Text] [Related]  

  • 32. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.
    Sakorafas GH; Friess H; Peros G
    Endocr Relat Cancer; 2008 Dec; 15(4):871-84. PubMed ID: 19015274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paresthetic notalgia and multiple endocrine neoplasia type 2a (Sipple's syndrome): 3 cases].
    Rivollier C; Emy P; Armingaud P; Buzacoux J; Chadenas D; Legoux A; Estève E
    Ann Dermatol Venereol; 1999; 126(6-7):522-4. PubMed ID: 10495863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia syndromes.
    Callender GG; Rich TA; Perrier ND
    Surg Clin North Am; 2008 Aug; 88(4):863-95, viii. PubMed ID: 18672144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of labetalol in the anesthetic management of pheochromocytoma].
    Armero R; Vicente R; Alepuz R
    Rev Esp Anestesiol Reanim; 1999 Apr; 46(4):176-7. PubMed ID: 10365617
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?
    Dotzenrath C; Cupisti K; Goretzki PE; Yang Q; Simon D; Ohmann C; Röher HD
    Eur J Surg; 2001 Mar; 167(3):173-8. PubMed ID: 11316400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular influences in thyroid and parathyroid surgery.
    Mihai R
    Best Pract Res Clin Endocrinol Metab; 2001 Jun; 15(2):177-88. PubMed ID: 11472033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early surgical intervention and strategy in patients with multiple endocrine neoplasia type 1.
    Gauger PG; Thompson NW
    Best Pract Res Clin Endocrinol Metab; 2001 Jun; 15(2):213-23. PubMed ID: 11472035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment.
    Kaczirek K; Prager G; Schindl M; Kaserer K; Gessl A; Vierhapper H; Niederle B
    Wien Klin Wochenschr; 2002 Apr; 114(7):258-66. PubMed ID: 12089861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgery of adrenal glands in multiple endocrine neoplasms].
    Henry JF
    Ann Ital Chir; 1994; 65(1):39-42. PubMed ID: 7978744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.